GlassScriptPhysician profile
Kent D Branson
NPI 1427149038
$2,653.66
in general payments reported to CMS, 2019-2025
18 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,759 · 2020: $190 · 2021: $302 · 2022: $79.59 · 2023: $61.41 · 2024: $112 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $323.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $323.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $1,608.89 | 2019 | |
| Evofem Biosciences, INC. | $398.31 | 2020-2025 | Phexxi, Solosec, Phexx |
| Abbvie INC. | $246.99 | 2019-2025 | |
| Exeltis, USA INC. | $82.87 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $74.14 | 2025 | |
| Allergan, INC. | $50.50 | 2019-2020 | |
| Vertical Pharmaceuticals, LLC | $46.05 | 2019 | |
| Lupin INC. | $38.02 | 2020 | |
| Mission Pharmacal Company | $25.52 | 2019 | |
| Sumitomo Pharma America, INC. | $22.83 | 2025 | Myfembree |
| Abbott Laboratories | $19.19 | 2024 | Freestyle Libre 3 |
| Hologic Sales and Service, LLC | $15.68 | 2024 | Omni Hysteroscope |
| Aesculap, INC. | $12.65 | 2019 | |
| Therapeuticsmd, INC. | $12.02 | 2020 |
4 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kent Branson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.